Cancer statistics, 2022
- PMID: 35020204
- DOI: 10.3322/caac.21708
Cancer statistics, 2022
Abstract
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths in the United States and compiles the most recent data on population-based cancer occurrence and outcomes. Incidence data (through 2018) were collected by the Surveillance, Epidemiology, and End Results program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data (through 2019) were collected by the National Center for Health Statistics. In 2022, 1,918,030 new cancer cases and 609,360 cancer deaths are projected to occur in the United States, including approximately 350 deaths per day from lung cancer, the leading cause of cancer death. Incidence during 2014 through 2018 continued a slow increase for female breast cancer (by 0.5% annually) and remained stable for prostate cancer, despite a 4% to 6% annual increase for advanced disease since 2011. Consequently, the proportion of prostate cancer diagnosed at a distant stage increased from 3.9% to 8.2% over the past decade. In contrast, lung cancer incidence continued to decline steeply for advanced disease while rates for localized-stage increased suddenly by 4.5% annually, contributing to gains both in the proportion of localized-stage diagnoses (from 17% in 2004 to 28% in 2018) and 3-year relative survival (from 21% to 31%). Mortality patterns reflect incidence trends, with declines accelerating for lung cancer, slowing for breast cancer, and stabilizing for prostate cancer. In summary, progress has stagnated for breast and prostate cancers but strengthened for lung cancer, coinciding with changes in medical practice related to cancer screening and/or treatment. More targeted cancer control interventions and investment in improved early detection and treatment would facilitate reductions in cancer mortality.
Keywords: cancer cases; cancer statistics; death rates; incidence; mortality.
© 2022 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.
Similar articles
-
Cancer statistics, 2020.CA Cancer J Clin. 2020 Jan;70(1):7-30. doi: 10.3322/caac.21590. Epub 2020 Jan 8. CA Cancer J Clin. 2020. PMID: 31912902
-
Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics.J Natl Cancer Inst. 2021 Nov 29;113(12):1648-1669. doi: 10.1093/jnci/djab131. J Natl Cancer Inst. 2021. PMID: 34240195 Free PMC article.
-
Cancer Statistics, 2021.CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12. CA Cancer J Clin. 2021. PMID: 33433946
-
Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control.J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99. doi: 10.1093/jnci/djg040. J Natl Cancer Inst. 2003. PMID: 12953083 Review.
-
Breast cancer statistics, 2011.CA Cancer J Clin. 2011 Nov-Dec;61(6):409-18. doi: 10.3322/caac.20134. Epub 2011 Oct 3. CA Cancer J Clin. 2011. PMID: 21969133 Review.
Cited by
-
Quantitative computed tomography assessment of pulmonary function and compensation after lobectomy and segmentectomy in lung cancer patients.J Thorac Dis. 2024 Sep 30;16(9):5765-5778. doi: 10.21037/jtd-24-492. Epub 2024 Sep 6. J Thorac Dis. 2024. PMID: 39444877 Free PMC article.
-
Preliminary Study on Pharmacokinetics and Antitumor Pharmacodynamics of Folic Acid Modified Crebanine Polyethyleneglycol-Polylactic Acid Hydroxyacetic Acid Copolymer Nanoparticles.Int J Nanomedicine. 2024 Oct 17;19:10513-10536. doi: 10.2147/IJN.S477027. eCollection 2024. Int J Nanomedicine. 2024. PMID: 39435040 Free PMC article.
-
Treatment of a mutant KRAS lung cancer cell line with polyisoprenylated cysteinyl amide inhibitors activates the MAPK pathway, inhibits cell migration and induces apoptosis.PLoS One. 2024 Oct 22;19(10):e0312563. doi: 10.1371/journal.pone.0312563. eCollection 2024. PLoS One. 2024. PMID: 39436906 Free PMC article.
-
Incidence and Pattern of Recurrence after Surgical Resection in Organ-Confined Renal Cell Carcinoma.Yonsei Med J. 2024 Nov;65(11):623-628. doi: 10.3349/ymj.2023.0587. Yonsei Med J. 2024. PMID: 39439165 Free PMC article.
-
Identification of exosomal ceRNA networks as prognostic markers in clear cell renal cell carcinoma.Medicine (Baltimore). 2024 Oct 25;103(43):e40167. doi: 10.1097/MD.0000000000040167. Medicine (Baltimore). 2024. PMID: 39470474 Free PMC article.
References
-
- Yabroff, K. R., Wu, X. C., Negoita, S., Stevens, J., Coyle, L., Zhao, J., Mumphrey, B. J., Jemal, A., Ward, K. C. Association of the COVID-19 Pandemic with Patterns of Statewide Cancer Services. J Natl Cancer Inst. June 28 2021.
-
- Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 9 Registries Research Data with Delay-Adjustment, Malignant Only, November 2020 Submission (1975-2018) <Katrina/Rita Population Adjustment>-Linked To County Attributes-Total U.S., 1969-2018 Counties. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2021.
-
- Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER 18 Registries Research Data + Hurricane Katrina Impacted Louisiana Cases, November 2020 Submission (2000-2018) <Katrina/Rita Population Adjustment>-Linked To County Attributes-Total U.S., 1969-2018 Counties. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program, Surveillance Systems Branch; 2021.
-
- Surveillance Research Program. SEER*Explorer: an interactive website for SEER cancer statistics. National Cancer Institute; 2021. Accessed April 15, 2021. seer.cancer.gov/explorer/
-
- Surveillance, Epidemiology, and End Results (SEER) Program. SEER*Stat Database: Incidence-SEER Research Limited-Field Data With Delay-Adjustment, 21 Registries, Malignant Only, November 2020 Submission (2000-2018)-Linked To County Attributes-Time Dependent (1990-2018) Income/Rurality, 1969-2019 Counties. National Cancer Institute, Division of Cancer Control and Population Sciences, Surveillance Research Program; 2021.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous